301617 Stock Overview

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. More details

301617 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	4/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (27.1x) is below the CN market (36.3x)

Earnings grew by 16% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. Competitors

Nanjing COSMOS Chemical

SZSE:300856

CN¥9.1b

Sanxiang Advanced Materials

SHSE:603663

CN¥7.0b

GCH Technology

SHSE:688625

CN¥5.4b

Suzhou Shihua New Material Technology

SHSE:688093

CN¥5.4b

Price History & Performance

Summary of share price highs, lows and changes for Shandong Boyuan Pharmaceutical & Chemical
Historical stock prices
Current Share Price	CN¥55.26
52 Week High	CN¥107.66
52 Week Low	CN¥54.61
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-30.99%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	301617	CN Chemicals	CN Market
7D	-13.9%	-4.8%	-3.5%
1Y	n/a	0.9%	10.9%

Return vs Industry: Insufficient data to determine how 301617 performed against the CN Chemicals industry.

Return vs Market: Insufficient data to determine how 301617 performed against the CN Market.

Price Volatility

Is 301617's price volatile compared to industry and market?
301617 volatility
301617 Average Weekly Movement	n/a
Chemicals Industry Average Movement	8.2%
Market Average Movement	8.7%
10% most volatile stocks in CN Market	12.8%
10% least volatile stocks in CN Market	5.7%

Stable Share Price: 301617's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: Insufficient data to determine 301617's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2008	n/a	n/a	www.boyuanchemical.com

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sales of fine chemicals. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodide, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, and tris[2-(2-methoxyethoxy)ethyl]amine.

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. Fundamentals Summary

How do Shandong Boyuan Pharmaceutical & Chemical's earnings and revenue compare to its market cap?
301617 fundamental statistics
Market cap	CN¥5.68b
Earnings (TTM)	CN¥209.51m
Revenue (TTM)	CN¥1.29b

27.1x

P/E Ratio

4.4x

P/S Ratio

Is 301617 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301617 income statement (TTM)
Revenue	CN¥1.29b
Cost of Revenue	CN¥970.76m
Gross Profit	CN¥314.98m
Other Expenses	CN¥105.47m
Earnings	CN¥209.51m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	2.04
Gross Margin	24.50%
Net Profit Margin	16.29%
Debt/Equity Ratio	0%

How did 301617 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 19:36
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution